Walter & Keenan Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $335K | Sell |
5,528
-488
| -8% | -$28.4K | 0.09% | 128 |
|
|
2025
Q4 | $325K | Sell |
6,016
-296
| -5% | -$14.2K | 0.09% | 130 |
|
|
2025
Q3 | $285K | Sell |
6,312
-1,218
| -16% | -$56.9K | 0.08% | 137 |
|
|
2025
Q2 | $349K | Sell |
7,530
-1,811
| -19% | -$88.9K | 0.1% | 124 |
|
|
2025
Q1 | $570K | Buy |
9,341
+115
| +1% | +$6.7K | 0.17% | 100 |
|
|
2024
Q4 | $522K | Sell |
9,226
-524
| -5% | -$29.3K | 0.16% | 103 |
|
|
2024
Q3 | $504K | Sell |
9,750
-246
| -2% | -$11.5K | 0.15% | 105 |
|
|
2024
Q2 | $415K | Sell |
9,996
-210
| -2% | -$9.4K | 0.13% | 108 |
|
|
2024
Q1 | $553K | Buy |
10,206
+1,142
| +13% | +$58.2K | 0.18% | 99 |
|
|
2023
Q4 | $465K | Sell |
9,064
-700
| -7% | -$36.7K | 0.17% | 103 |
|
|
2023
Q3 | $567K | Buy |
9,764
+39
| +0.4% | +$2.39K | 0.22% | 92 |
|
|
2023
Q2 | $622K | Buy |
9,725
+75
| +0.8% | +$5.03K | 0.23% | 90 |
|
|
2023
Q1 | $669K | Sell |
9,650
-5,500
| -36% | -$388K | 0.25% | 88 |
|
|
2022
Q4 | $1.09M | Buy |
15,150
+550
| +4% | +$41.5K | 0.43% | 62 |
|
|
2022
Q3 | $1.04M | Buy |
14,600
+504
| +4% | +$36.6K | 0.44% | 57 |
|
|
2022
Q2 | $1.08M | Sell |
14,096
-425
| -3% | -$32.4K | 0.43% | 57 |
|
|
2022
Q1 | $1.06M | Hold |
14,521
| – | – | 0.36% | 66 |
|
|
2021
Q4 | $905K | Hold |
14,521
| – | – | 0.29% | 73 |
|
|
2021
Q3 | $859K | Buy |
14,521
+945
| +7% | +$62.2K | 0.29% | 79 |
|
|
2021
Q2 | $907K | Buy |
13,576
+3,175
| +31% | +$207K | 0.31% | 76 |
|
|
2021
Q1 | $657K | Sell |
10,401
-800
| -7% | -$49.8K | 0.23% | 84 |
|
|
2020
Q4 | $695K | Buy |
11,201
+100
| +0.9% | +$6.15K | 0.25% | 82 |
|
|
2020
Q3 | $669K | Sell |
11,101
-46
| -0.4% | -$2.77K | 0.27% | 80 |
|
|
2020
Q2 | $655K | Buy |
+11,147
| New | +$667K | 0.27% | 79 |
|
|
2020
Q1 | – | Sell |
-11,101
| Closed | -$713K | – | 121 |
|
|
2019
Q4 | $713K | Buy |
11,101
+380
| +4% | +$21.8K | 0.27% | 79 |
|
|
2019
Q3 | $544K | Buy |
10,721
+1,570
| +17% | +$73.8K | 0.21% | 93 |
|
|
2019
Q2 | $415K | Buy |
9,151
+500
| +6% | +$23.3K | 0.18% | 95 |
|
|
2019
Q1 | $413K | Buy |
8,651
+201
| +2% | +$10K | 0.18% | 98 |
|
|
2018
Q4 | $439K | Hold |
8,450
| – | – | 0.2% | 90 |
|
|
2018
Q3 | $525 | Sell |
8,450
-150
| -2% | -$8.9K | 0.16% | 93 |
|
|
2018
Q2 | $476K | Buy |
8,600
+150
| +2% | +$8.1K | 0.2% | 94 |
|
|
2018
Q1 | $534K | Hold |
8,450
| – | – | 0.23% | 88 |
|
|
2017
Q4 | $518K | Hold |
8,450
| – | – | 0.22% | 87 |
|
|
2017
Q3 | $559K | Hold |
8,450
| – | – | 0.26% | 82 |
|
|
2017
Q2 | $471K | Sell |
8,450
-450
| -5% | -$24.5K | 0.24% | 88 |
|
|
2017
Q1 | $484K | Sell |
8,900
-314
| -3% | -$17.2K | 0.25% | 86 |
|
|
2016
Q4 | $538K | Buy |
9,214
+464
| +5% | +$25.4K | 0.29% | 76 |
|
|
2016
Q3 | $472K | Buy |
8,750
+625
| +8% | +$40.1K | 0.26% | 83 |
|
|
2016
Q2 | $598K | Sell |
8,125
-925
| -10% | -$65.4K | 0.33% | 72 |
|
|
2016
Q1 | $578K | Sell |
9,050
-200
| -2% | -$12.6K | 0.33% | 75 |
|
|
2015
Q4 | $636K | Hold |
9,250
| – | – | 0.37% | 66 |
|
|
2015
Q3 | $548K | Hold |
9,250
| – | – | 0.34% | 71 |
|
|
2015
Q2 | $615K | Buy |
9,250
+400
| +5% | +$26.4K | 0.36% | 71 |
|
|
2015
Q1 | $571K | Hold |
8,850
| – | – | 0.32% | 77 |
|
|
2014
Q4 | $522K | Hold |
8,850
| – | – | 0.3% | 81 |
|
|
2014
Q3 | $453K | Hold |
8,850
| – | – | 0.27% | 90 |
|
|
2014
Q2 | $429K | Buy |
8,850
+500
| +6% | +$24.6K | 0.22% | 98 |
|
|
2014
Q1 | $434K | Buy |
+8,350
| New | +$444K | 0.24% | 91 |
|
Other funds holding BMY
VCM
VPM
Walter & Keenan Wealth Management's BMY Position: Q1 2026 in Review
Walter & Keenan Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 8.1% in Q1 2026, selling an estimated $28.4K and leaving 5,528 shares worth $335K. The position accounts for 0.09% of the portfolio, ranked #128.
Walter & Keenan Wealth Management first reported a position in BMY in Q1 2014 and has held it in 48 quarters since. The position peaked at $1.09M in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Walter & Keenan Wealth Management held 5,528 shares of Bristol-Myers Squibb worth $335K as of Q1 2026.
- Walter & Keenan Wealth Management sold 488 Bristol-Myers Squibb shares in Q1 2026, an estimated $28.4K.
- Bristol-Myers Squibb made up 0.09% of Walter & Keenan Wealth Management's portfolio in Q1 2026, its #128 holding.
- Walter & Keenan Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2014 and has held it in 48 quarters since.
- Walter & Keenan Wealth Management's Bristol-Myers Squibb position peaked at $1.09M in Q4 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Walter & Keenan Wealth Management's 13F filing for Q1 2026, filed 11 May 2026.